Wird geladen...
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Alzheimer’s disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood–brain barrie...
Gespeichert in:
| Veröffentlicht in: | Int J Nanomedicine |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4531021/ https://ncbi.nlm.nih.gov/pubmed/26345528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S87148 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|